Cart
0
Get 20% Free Customization In This Report
Buy this report from - $2481

Europe In Vitro Fertilization (IVF) Market by Cycle Type (Fresh Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycle) and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes) - Opportunity Analysis and Industry Forecast, 2014-2022

LI 161823
Pages: 148
Dec 2016 | 2048 Views
face gplus_n
Author's : Pallavi Jaiswal
Tables: 57
Charts: 57
twit_n pr_n

Europe In Vitro Fertilization (IVF) Market Overview:

The European IVF Market was valued at $3,054 million in 2015 and is estimated to reach $4,447 million by 2022, growing at a CAGR of 5.4% during the analysis period. In vitro fertilization is a type of assisted reproductive technology-based fertility treatment across the clinical industry. Delayed pregnancy in women is a major factor that drives the IVF market, as the chances of conceiving lowers with age. The success rate of getting pregnant with IVF technique is higher in the age group of 35‐39 years.

The major factors that limit this market growth are cost incurred and stringent government regulations. A patient may need to undergo several cycles of pregnancy owing to the lower success rate of IVF procedures, thereby adding to the overall cost. The average cost of this procedure is approximately $10,000‐$20,000, which often acts as a major limitation, to the adoption of the technique. In addition, ethical considerations and lack of reimbursements are other challenges that impede the market growth. The companies profiled in this report include Thermo Fisher Scientific, Inc., DRK Kliniken Berlin, Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., LG Life Sciences, and EMD Serono Inc.
 
IVF Success Rates According to Age in the UK
 
IVF Success Rates According to Age in the UK
Source: Human Fertilization and Embryology Authority Website

The growing trends of delayed pregnancy have steadily increased across Europe and other countries. In older women, eggs produced by the reproductive system are less efficient for the process of fertilization with the male spermatozoa, resulting in risk of genetic disorders. According to Centers for Disease Control and Prevention (CDC), the rate of fertilization in the age group of 35‐39 years through IVF is considerably high.
 
Denmark In Vitro Fertilization Market, Volume and Value, 2014-2022 (Thousand, $Million)
 
Denmark In Vitro Fertilization Market, Volume and Value, 2014-2022 (Thousand, $Million)
 
IVF techniques play a significant role in addressing infertility. The success rates in Denmark range from 26% to 29% for patients in the age group of 25‐37 years. The pregnancy rate is 12‐16% for the age group of 37‐45 years; however, clinicians claim that there are more chances of miscarriage in this age group, resulting in birth rate of about 8‐10%. A single standard IVF cycle in Denmark costs approximately $4,800, which is less than that in the rest of European countries. However, these costs are higher as compared to that in Russia and Spain.

The key companies offering these products includes include Thermo Fisher Scientific, Inc., DRK Kliniken Berlin, Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., LG Life Sciences, and EMD Serono Inc

Key Benefits for Stakeholders:
 
  • This report provides an in-depth analysis of the European IVF market across eight major countries along with cross-sectional analysis of the total number of IVF cycles performed and the total revenue generated during the forecast period.
  • It includes the strategies adopted by various IVF clinics and hospitals across major countries to capitalize on the latent opportunities in the market.
  • The projections are made by analyzing the current market trends and highlighting the market potential, in terms of value and volume, from 2015 to 2022.
  • Extensive analysis of the market is conducted by following the key product positioning and monitoring the top contenders.

Europe In Vitro Fertilization (IVF) Market Key Segments:

By End Users (Value and Volume)

  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes

By Cycle Type (Value and Volume)

  • Fresh Cycle (Non-Donor)
  • Thawed IVF Cycle (Non-Donor)
  • Donor Egg IVF Cycle

By Cycle Type Country Level Analysis (Value and Volume)

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Denmark
  • Russia
  • Rest of Europe
 

Chapter: 1 INTRODUCTION

1.1 Report Description
1.2 Key Benefits
1.3 Coverage and Limitations
1.4 Research Methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

Chapter: 3 EUROPE IVF MARKET ANALYSIS

3.1 Market Definition and Scope
3.2 Overview
3.3 Drivers

3.3.1 Delayed pregnancies in women
3.3.2 Supportive regulations

3.4 Restraints

3.4.1 Inadequate reimbursement policies
3.4.2 Ethical considerations

3.5 Europe IVF Market by Country
3.6 Europe IVF Market by Cycle Type
3.7 Europe IVF Market by End Users
3.8 Company Profile

3.8.1 Thermo Fisher Scientific, Inc.
3.8.2 DRK Kliniken Berlin
3.8.3 Sun Pharmaceutical Industries Ltd.
3.8.4 Cadila Healthcare Ltd. (Zydus Cadila Group)
3.8.5 LG Life Sciences

Chapter: 4 GERMANY EMBRYO TRANSFER MARKET

4.1 Overview
4.2 Germany IVF Market by Cycle Type

4.2.1 Fresh IVF cycles (non-donor)
4.2.2 Thawed IVF cycles (non-donor)

4.3 Number of Infertility Clinics, 2015
4.4 Germany IVF Market by End Users

4.4.1 Fertility clinics
4.4.2 Hospitals
4.4.3 Surgical centers
4.4.4 Clinical research institutes

4.5 Drivers

4.5.1 Subsidizing IVF treatments
4.5.2 Delayed marriages and parenthood decisions

4.6 Restraints

4.6.1 Stringent government regulations
4.6.2 Lack of availability in treatment cycles for IVF

4.7 Regulatory Issues, Legislations, and Authorities
4.8 Insurance Reimbursement Scenario
4.9 Hospitals/Clinics Profile

4.9.1 Heidelberg University Hospital
4.9.2 Klinikum Stuttgart
4.9.3 DRK Kliniken Berlin
4.9.4 University Medical Center Freiburg

Chapter: 5 FRANCE EMBRYO TRANSFER MARKET

5.1 Overview
5.2 France IVF Market by Cycle Type

5.2.1 Fresh IVF cycles (non-donor)
5.2.2 Thawed IVF cycles (non-donor)
5.2.3 Donor egg IVF cycles

5.3 Number of Infertility Clinics, 2015
5.4 France IVF Market by End Users

5.4.1 Fertility clinics
5.4.2 Hospitals
5.4.3 Surgical centers
5.4.4 Clinical research institutes

5.5 Drivers

5.5.1 Same gender adoption of IVF babies
5.5.2 Lower rates of fertility

5.6 Restraints

5.6.1 Stringent government regulations

5.7 Regulatory Issues, Legislations, and Authorities
5.8 Insurance Reimbursement Scenario
5.9 Hospitals/Clinics Profile

5.9.1 Clinique de la Muette
5.9.2 Hopital des metallurgists, hopital cochin

Chapter: 6 UK EMBRYO TRANSFER MARKET

6.1 Overview
6.2 UK IVF Market by Cycle Type

6.2.1 Fresh IVF cycles (non-donor)
6.2.2 Thawed IVF cycles (non-donor)
6.2.3 Donor egg IVF cycles

6.3 Number of Infertility Clinics, 2015
6.4 UK IVF Market by End Users

6.4.1 Fertility clinics
6.4.2 Hospitals
6.4.3 Surgical centers
6.4.4 Clinical research institutes

6.5 Drivers

6.5.1 Commercialization of three-parent IVF procedures
6.5.2 Supportive regulations

6.6 Restraints

6.6.1 Ethical considerations

6.7 Regulatory Issues, Legislations, and Authorities
6.8 Insurance Reimbursement Scenario
6.9 Hospitals/Clinics Profile

6.9.1 Lister Fertility Clinic
6.9.2 The Bridge Center
6.9.3 Chelsea and Westminster Hospital (Assisted Conception Unit)

Chapter: 7 ITALY EMBRYO TRANSFER MARKET

7.1 Overview
7.2 Italy IVF Market by Cycle Type

7.2.1 Fresh IVF cycles (non-donor)
7.2.2 Thawed IVF cycles (non-donor)

7.3 Italy IVF Market by End Users

7.3.1 Fertility clinics
7.3.2 Hospitals
7.3.3 Surgical centers
7.3.4 Clinical research institutes

7.4 Drivers

7.4.1 Growing medical tourism

7.5 Restraints

7.5.1 Ban on surrogacy

7.6 Regulatory issues, legislations, and authorities
7.7 Insurance Reimbursement Scenario
7.8 Hospitals/Clinics Profile

7.8.1 ARC-STER srl
7.8.2 RAPRUI
7.8.3 Centre for Reproductive Medicine-Napoli

Chapter: 8 SPAIN EMBRYO TRANSFER MARKET

8.1 Overview
8.2 Spain IVF Market by Cycle Type

8.2.1 Fresh IVF cycles (non-donor)
8.2.2 Thawed IVF cycles (non-donor)
8.2.3 Donor egg IVF cycles

8.3 Spain IVF Market by End Users

8.3.1 Fertility clinics
8.3.2 Hospitals
8.3.3 Surgical centers
8.3.4 Clinical research institutes

8.4 Drivers

8.4.1 Increase in the number of foreign patients

8.5 Restraints

8.5.1 Low awareness pertaining to IVF technology

8.6 Regulatory Issues, Legislations, and Authorities

8.7 Insurance Reimbursement Scenario
8.8 Hospitals/Clinics Profiles

8.8.1.1 IVF spain
8.8.1.2 Clnica EUGIN Barcelona

Chapter: 9 DENMARK EMBRYO TRANSFER MARKET

9.1 Overview
9.2 Denmark IVF Market by Cycle Type

9.2.1 Fresh IVF cycles (non-donor)
9.2.2 Thawed IVF cycles (non-donor)
9.2.3 Donor egg IVF cycles

9.3 Denmark IVF Market by End Users

9.3.1 Fertility clinics
9.3.2 Hospitals
9.3.3 Surgical centers
9.3.4 Clinical research institutes

9.4 Drivers

9.4.1 Increase in disposable income
9.4.2 Advances in IVF technology

9.5 Restraints

9.5.1 Inadequate reimbursement policies

9.6 Regulatory Issues, Legislations, and Authorities
9.7 Insurance Reimbursement Scenario
9.8 Hospitals/Clinics Profiles

9.8.1 Copenhagen Fertility Center
9.8.2 Storkklinik v/Nina Stork
9.8.3 Vitanova
9.8.4 Trianglen fertility clinic
9.8.5 NordicaDenmark, Copenhagen

Chapter: 10 RUSSIA EMBRYO TRANSFER MARKET

10.1 Overview
10.2 Russia IVF Market by Cycle Type

10.2.1 Fresh IVF cycles (non-donor)
10.2.2 Thawed IVF cycles (non-donor)
10.2.3 Donor egg IVF cycles

10.3 Russia IVF Market by End User

10.3.1 Fertility clinics
10.3.2 Hospitals
10.3.3 Surgical centers
10.3.4 Clinical research institutes

10.4 Drivers

10.4.1 Rising popularity of fertility tourism

10.5 Restraints

10.5.1 Inadequate reimbursement policies

10.6 Regulatory Issues, Legislations, and Authorities
10.7 Insurance Reimbursement Scenario
10.8 Hospital/Clinics Profiles

10.8.1 AVA-Peter Clinic
10.8.2 MD Medical Group
10.8.3 IVF Russia (The International Centre of the Reproductive Medicines)

Chapter: 11 REST OF EUROPE EMBRYO TRANSFER MARKET

11.1 Overview
11.2 Rest of Europe IVF Market by Cycle Type

11.2.1 Fresh IVF cycles (non-donor)
11.2.2 Thawed IVF cycles (non-donor)
11.2.3 Donor egg IVF cycles

11.3 Rest of Europe IVF Market by End Users

11.3.1 Fertility clinics
11.3.2 Hospitals
11.3.3 Surgical centers
11.3.4 Clinical research institutes

11.4 Drivers

11.4.1 Wide availability of reimbursements
11.4.2 Emergence of new fertility destinations
11.4.3 Changes in lifestyle

11.5 Restraints
11.6 Regulatory Issues, Legislations, and Authorities
11.7 Insurance Reimbursement Scenario
11.8 Hospitals/Clinics Profiles

11.8.1 Gynaecoloqisch Centrum
11.8.2 Centrum Voor Medische Genetica
11.8.3 Infertility-Vestliitto

List of Figures

FIG. 1 GERMANY IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 2 GERMANY IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 3 GERMANY IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 4 GERMANY IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 5 GERMANY IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 6 GERMANY IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 7 REGULATORY SCENARIO, GERMANY
FIG. 8 FRANCE IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 9 FRANCE IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 10 FRANCE IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 11 FRANCE IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 12 FRANCE IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 13 FRANCE IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 14 FRANCE IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 15 FRANCE: REGULATORY SCENARIO
FIG. 16 UK IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 17 UK IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 18 UK IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 19 UK IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 20 UK IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 21 UK IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 22 UK IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 23 UK: REGULATORY SCENARIO
FIG. 24 ITALY IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 25 ITALY IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 26 ITALY IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 27 ITALY IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 28 ITALY IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 29 ITALY IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 30 SPAIN IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 31 SPAIN IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 32 SPAIN IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 33 SPAIN IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 34 SPAIN IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 35 SPAIN IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 36 SPAIN IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 37 DENMARK IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 38 DENMARK IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 39 DENMARK IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 40 DENMARK IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 41 DENMARK IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 42 DENMARK IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 43 DENMARK IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 44 RUSSIA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 45 RUSSIA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 46 RUSSIA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 47 RUSSIA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 48 RUSSIA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 49 RUSSIA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 50 RUSSIA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 51 REST OF EUROPE IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 52 REST OF EUROPE IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 53 REST OF EUROPE IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 54 REST OF EUROPE IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 55 REST OF EUROPE IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 56 REST OF EUROPE IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)
FIG. 57 REST OF EUROPE IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND AND $MILLION)

List of Tables

TABLE 1 IVF SUCCESS RATES ACCORDING TO AGE
TABLE 2 EUROPE, IVF MARKET, 2014-2022 (THOUSAND)
TABLE 3 EUROPE, IVF MARKET, 2014-2022 ($MILLION)
TABLE 4 EUROPE IVF MARKET, BY CYCLE TYPE, 2014-2022, (THOUSAND)
TABLE 5 EUROPE IVF MARKET, BY CYCLE TYPE, 2014-2022, ($MILLION)
TABLE 6 EUROPE IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 7 EUROPE IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 8 THERMO FISHER SCIENTIFIC, INC. BUSINESS OVERVIEW
TABLE 9 COMPANY SNAPSHOT
TABLE 10 DRK KLINIKEN BERLIN OVERVIEW
TABLE 11 SNAPSHOT OF DRK KLINIKEN BERLIN
TABLE 12 SUN PHARMACEUTICAL BUSINESS OVERVIEW
TABLE 13 COMPANY SNAPSHOT
TABLE 14 CADILA HEALTH CARE BUSINESS OVERVIEW
TABLE 15 COMPANY SNAPSHOT
TABLE 16 LG LIFE SCIENCE BUSINESS OVERVIEW
TABLE 17 COMPANY SNAPSHOT
TABLE 18 GERMANY IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 19 GERMANY IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 20 GERMANY IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 21 GERMANY IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 22 GERMANY IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 23 HEIDELBERG UNIVERSITY HOSPITAL OVERVIEW
TABLE 24 SNAPSHOT OF HEIDELBERG UNIVERSITY HOSPITAL
TABLE 25 KLINIKUM STUTTGART OVERVIEW
TABLE 26 COMPANY SNAPSHOT
TABLE 27 DRK KLINIKEN BERLIN OVERVIEW
TABLE 28 SNAPSHOT OF DRK KLINIKEN BERLIN
TABLE 29 UNIVERSITY MEDICAL CENTER FREIBURG OVERVIEW
TABLE 30 SNAPSHOT OF UNIVERSITY MEDICAL CENTER FREIBURG
TABLE 31 FRANCE IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 32 FRANCE IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 33 FRANCE IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 34 FRANCE IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 35 FRANCE IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 36 CLINIQUE DE LA MUETTE OVERVIEW
TABLE 37 SNAPSHOT OF CLINIQUE DE LA MUETTE
TABLE 38 HOPITAL DES METALLURGISTS, HOPITAL COCHIN OVERVIEW
TABLE 39 SNAPSHOT OF HOPITAL DES METALLURGISTS, HOPITAL COCHIN
TABLE 40 UK: IVF CYCLES BY VARIOUS AGE GROUPS, 2011
TABLE 41 UK: PROPORTION OF IVF CYCLES USING FRESH AND FROZEN EGGS, 2010-2011
TABLE 42 UK: IVF SUCCESS RATES (AS PER NHS), 2010
TABLE 43 UK: REGIONAL IVF CLINICS AND TOTAL NUMBER OF WOMEN TREATED, 2011
TABLE 44 UK IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 45 UK IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 46 UK IVF MARKET BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 47 UK IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 48 UK IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 49 LISTER FERTILITY CLINIC OVERVIEW
TABLE 50 COMPANY SNAPSHOT
TABLE 51 THE BRIDGE CENTER OVERVIEW
TABLE 52 SNAPSHOT OF THE BRIDGE CENTER
TABLE 53 CHELSEA AND WESTMINSTER HOSPITAL OVERVIEW
TABLE 54 SNAPSHOT OF CHELSEA AND WESTMINSTER HOSPITAL
TABLE 55 ITALY IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 56 ITALY IVF MARKE, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 57 ITALY IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 58 ITALY IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 59 ITALY IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 60 SPAIN IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 61 SPAIN IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 62 SPAIN IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 63 SPAIN IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 64 SPAIN IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 65 DENMARK IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 66 DENMARK IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 67 DENMARK IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 68 DENMARK IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 69 DENMARK IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 70 RUSSIA IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 71 RUSSIA IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 72 RUSSIA IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 73 RUSSIA IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 74 RUSSIA IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 75 REST OF EUROPE IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSNAD AND $MILLION)
TABLE 76 REST OF EUROPE IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 77 REST OF EUROPE IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 78 REST OF EUROPE IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 79 REST OF EUROPE IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)

 

The emerging trend of delayed pregnancies and increasing average age of parenthood over the last decade are major factors that drive the growth of the IVF market. France has witnessed a rise in trend in same-sex couples seeking parenthood. In addition, polygamy and polyandry have also increased, though to a lesser extent, increasing the demand for alternative reproductive treatments. Countries such as UK have recently accepted three-parent IVF methods, commonly banned in other countries worldwide. This method is expected to boost the growth of UK IVF market owing to its inherent benefits of avoiding gene-linked mitochondrial DNA diseases in newborns.

The growth in government interventions and support, especially in UK where lower fertility, aging population, and lack of workforce have triggered severe implications, is further expected to boost the market growth. Government support and regulations (such as HFEA act and guidelines), favorable policies such as three-parent IVF, and availability of reimbursements are expected to drive the UK IVF market growth at a CAGR higher than rest of the European countries.

 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 

Get More Information About This Report

For any queries about purchasing this report, Please fill the form below:

Please input the above text in the input box or click refresh

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts